Agilon Health Inc (NYSE: AGL) is -77.53% lower on its value in year-to-date trading and has touched a low of $2.77 and a high of $19.84 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The AGL stock was last observed hovering at around $2.81 in the last trading session, with the day’s gains setting it 0.01%.
Currently trading at $2.82, the stock is -15.33% and -25.64% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.45 million and changing 0.36% at the moment leaves the stock -48.79% off its SMA200. AGL registered -85.42% loss for a year compared to 6-month loss of -47.19%. The firm has a 50-day simple moving average (SMA 50) of $3.8428 and a 200-day simple moving average (SMA200) of $5.5358.
The stock witnessed a -26.56% gain in the last 1 month and extending the period to 3 months gives it a -58.28%, and is -15.06% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 8.25% over the week and 9.00% over the month.
Agilon Health Inc (AGL) has around 1117 employees, a market worth around $1.16B and $5.36B in sales. Profit margin for the company is -4.69%. Distance from 52-week low is 1.81% and -85.79% from its 52-week high. The company has generated returns on investments over the last 12 months (-35.16%).
with sales reaching $1.47B over the same period.The EPS is expected to grow by 25.75% this year, but quarterly earnings will post 39.60% year-over-year. Quarterly sales are estimated to grow 21.00% in year-over-year returns.
Agilon Health Inc (AGL) Top Institutional Holders
295.0 institutions hold shares in Agilon Health Inc (AGL), with institutional investors hold 113.49% of the company’s shares. The shares outstanding are 406.39M, and float is at 302.82M with Short Float at 12.05%. Institutions hold 111.46% of the Float.
The top institutional shareholder in the company is CLAYTON, DUBILIER & RICE, LLC with over 100.0 million shares valued at $654.0 million. The investor’s holdings represent 24.3149% of the AGL Shares outstanding. As of 2024-06-30, the second largest holder is FMR LLC with 56.93 million shares valued at $$372.3 million to account for 13.8418 of the shares outstanding. The other top investors are MORGAN STANLEY which holds 56.41 million shares representing 13.7168% and valued at over $368.94 million, while WELLINGTON MANAGEMENT GROUP LLP holds 13.4653 of the shares totaling 55.38 million with a market value of $362.18 million.
Agilon Health Inc (AGL) Insider Activity
The most recent transaction is an insider purchase by Sell Steven, the company’s CEO & President. SEC filings show that Sell Steven bought 20,000 shares of the company’s common stock on Sep 12 ’24 at a price of $3.36 per share for a total of $67188.0. Following the purchase, the insider now owns 67590.0 shares.
Agilon Health Inc disclosed in a document filed with the SEC on Nov 29 ’23 that Schwaneke Jeffrey A. (Director) bought a total of 22,300 shares of the company’s common stock. The trade occurred on Nov 29 ’23 and was made at $11.22 per share for $0.25 million. Following the transaction, the insider now directly holds 31931.0 shares of the AGL stock.
